Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naïve volunteers infected with HIV-1: A Randomized, controlled equivalence trial

The ACTG A5257 Team

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naïve volunteers infected with HIV-1: A Randomized, controlled equivalence trial'. Together they form a unique fingerprint.

Medicine & Life Sciences